Clinical Trials Browser

Phase 1 × Unknown × poly ICLC × Clear all

NCT05281926 2022-03-16

A Phase I, Open-label Study to Assess the Safety and Efficacy of Poly-ICLC Plus Nivolumab in Unresectable Hepatocellular Carcinoma Patients

Phase 1 Unknown

Gastrointestinal

Carcinoma, Hepatocellular